Flu researchers discover new mechanism for battling influenza

Flu researchers discover new mechanism for battling influenza
A student gets a flu shot on the CU campus. A new study reveals how the body attempts to fight flu on its own, and why it often loses. Credit: University of Colorado at Boulder

Just as flu season swings into full gear, researchers from the University of Colorado Boulder and University of Texas at Austin have uncovered a previously unknown mechanism by which the human immune system tries to battle the influenza A virus. The discovery sheds new light on how the virus—which kills 12,000 to 56,000 people in the United States annually—often wins, and it could ultimately lead to new treatments.

"We've solved a mystery, revealing a new aspect of our innate immune system and what flu has to do to get around it," says Nicholas Meyerson, a postdoctoral researcher in the BioFrontiers Institute and lead author of a paper published in the Nov. 8 issue of Cell Host and Microbe.

The findings, several years in the making, could lead to a better understanding of how the seasonal flu , which typically originates in birds, makes its way to humans. They could also inform development of next-generation antivirals able to combat a broad spectrum of , says co-senior author Robert Krug, a leading influenza researcher and professor at the University of Texas at Austin.

The paper focuses on two key molecular players in the story of : a human protein called TRIM25, which was recently discovered to play an important role in the human immune response to flu infection; and a protein called NS1 present in all strains of the influenza A virus and shown to bind TRIM25 to keep it from doing its job.

"We were basically trying to find out what TRIM25 was doing that flu did not want it to be doing and the role NS1 was playing in blocking that function," Krug said.

Through a series of laboratory tests, the team revealed two main findings:

TRIM25 acts earlier than previously believed, latching on to a critical and unique flu virus structure like a "molecular clamp" to keep the virus from replicating as soon as TRIM25 detects this unique structure.

NS1 produced by the flu virus can block this function of TRIM25, enabling flu to circumvent the immune response and cause infection.

Previous research had suggested that TRIM25 fought off flu by switching on what is known as the "interferon response"—a complex signaling pathway that arms through the body to fight off pathogens. But not all strains of influenza block this interferon signaling pathway, which led Meyerson to suspect another mechanism was at play in helping TRIM25 fight flu.

The paper reveals that TRIM25 is also a "restriction factor," a special protein present in the fastest-acting arm of the immune system, before spreading infection occurs.

"Restriction factors lie in wait, and should a virus be detected in one of your cells, they have immediate destructive ability," explains co-senior author Sara Sawyer, an associate professor of Molecular, Cellular and Developmental Biology (MCDB) at CU Boulder.

Flu uses its NS1 protein to evade TRIM25's early flu-fighting response, the researchers found.

To do the study, the researchers first infected transgenic cell lines loaded with nonhuman primate versions of TRIM25 with the human influenza A virus. They found that the cells fought off the virus far better than human versions of the TRIM25 protein.

"This told us that TRIM25 has the capacity to crush influenza, but that its human form was less active," Meyerson said.

To find out how it crushes influenza, the researchers combined purified TRIM25 with purified viral ribonucleoproteins (vRNPs)—eight-piece protein chains that house the influenza genome—and used state-of-the-art electron microscopy to take pictures of what happened.They found that TRIM25 appears to swiftly recognize the unique structure of vRNPs and clamps down on them to keep them from replicating inside the cell.Other experiments confirmed that the NS1 protein in flu virus inhibits this function.

They also found that TRIM25 (previously believed to be present only in the cell cytoplasm) is also present in the cell nucleus, which is the same cellular location where flu replication occurs.

Sawyer and Meyerson are now looking to further investigate the role TRIM25 plays in cross-species transmission of .

More studies are needed, but Krug believes new therapeutics could be designed to block the NS1 produced by the , hobbling its ability to evade the human immune system.

"If you could somehow block NS1 from acting, you could block all strains of the virus," he says.


Explore further

How influenza virus evades the body's immune response

More information: Nuclear TRIM25 Specifically Targets Influenza Virus Ribonucleoproteins to Block the Onset of RNA Chain Elongation. Cell Host and Microbe. DOI: dx.doi.org/10.1016/j.chom.2017.10.003
Journal information: Cell Host and Microbe

Citation: Flu researchers discover new mechanism for battling influenza (2017, November 3) retrieved 17 August 2019 from https://medicalxpress.com/news/2017-11-flu-mechanism-influenza.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
43 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more